Announcements

  • A red blood cell affected by sickle cell disease.

    Although CRISPR-based gene therapy for sickle cell disease offers transformative outcomes, drugmakers are striving to develop treatments that are easy to manufacture and can reach much larger numbers of patients.

  • Black target sybols on a green background

    On the first episode of our new podcast series, Associate Editor Cláudia Vilhena interviews Marcus Walker, first author of a fantastic story on engineered bacteria used to stain textiles. They dive into the behind-the-scenes of the paper, from the inspiration to combine microbiology and fashion to the economical and environmental implications of living biomaterials.

  • A yellow pill capsule with a radiation sign on its casing

    The commercial success of second-generation radiopharmaceuticals in oncology has re-ignited interest in this modality, resulting in a surge of dealmaking and increased venture financing for companies in the field.

Nature Biotechnology is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.

Advertisement

Advertisement

Nature Careers

Science jobs

Advertisement